Alzheimer's Association. (2013). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 9, 1–69.
American Diabetes Association. (2013a). Diabetes Basics: Diabetes Statistics. Alexandria, VA: American Diabetes Association.
American Diabetes Association. (2013b). Economic costs of diabetes in the US in 2012. Diabetes Care, 36, 1033–1046.
Boustani, M., Peterson, B., Hanson, L., Harris, R. and Lohr, K. N. (2003). Screening for dementia in primary care: a summary of the evidence for the US Preventive Services Task Force. Annals of Internal Medicine, 138, 927–937.
Cholerton, B., Baker, L. and Craft, S. (2013). Insulin, cognition, and dementia. European Journal of Pharmacology (Epub ahead of print). doi:10.1016/j.ejphar.2013.08.008.
Cukierman, T., Gerstein, H. C. and Williamson, J. D. (2005). Cognitive decline and dementia in diabetes – systematic overview of prospective observational studies. Diabetologia, 48, 2460–2469.
Curb, J. D.
et al. (1999). Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology, 52, 971–975.
Day, H. R., Parker, J. D. and Office of Analysis and Epidemiology. (2013). Self-report of diabetes and claims-based identification of diabetes among medicare beneficiaries. National Health Statistics Reports, 69, 1–15.
Elias, P. K.
et al. (1997). NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham study. Diabetes Care, 20, 1388–1395.
Francis, G. J.
et al. (2008). Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain, 131, 3311–3334.
et al. (2008). Enhanced risk for Alzheimer's disease in persons with type 2 diabetes and APOE e4: the Cardiovascular Health Study Cognition Study. Journal of the American Medical Association, 65, 89–93.
Kloppenborg, R. P., van den Berg, E., Kappele, L. J. and Biessels, G. J. (2008). Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. European Journal of Pharmacology, 585, 97–108.
Kroenke, K., Spitzer, R. L. and Williams, J. B. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41, 1284–1292.
Launer, L. J.
et al. (2011). Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurology, 10, 969–977.
Lu, F.-P., Lin, K.-P. and Kuo, H.-K. (2009). Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLOS One, 4, e4144.
et al. (2000). The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of dementia in nursing homes research group. Gerontologist, 40, 663–672.
Montaquila, J., Freedman, V. A., Edwards, B. and Kasper, J. D. (2012). National Health and Aging Trends Study Round 1 Sample Design and Selection. NHATS technical paper #1. Baltimore, MD: Johns Hopkins University School of Public Health.
Morris, J. C.
et al. (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39, 1159–1165.
Naor, M., Steingruber, H. J., Westhoff, K., Schottenfeld-Naor, Y. and Gries, A. F. (1997). Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. Journal of Diabetes and its Complications, 11, 40–46.
Peila, R., Rodriguez, B. L. and Launer, L. J. (2002). Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes, 51, 1256–1262.
Plassman, B. L.
et al. (2007). Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology, 29, 125–132.
Reijmer, Y. D., van den Berg, E., Ruis, C., Kappelle, L. J. and Biessels, G. J. (2010). Cognitive dysfunction in patients with type 2 diabetes. Diabetes/Metabolism Research and Review, 26, 507–519.
Roberts, R. O.
et al. (2008). Association of duration and severity of diabetes mellitus with mild cognitive impairment. Archives of Neurology, 65, 1066–1073.
Ryan, C. M., Freed, M. I., Rood, J. A., Cobitz, A. R., Waterhouse, B. R. and Strachan, M. W. (2006). Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care, 29, 345–351.
Schrijvers, E. M., Witteman, J. C., Sijbrands, E. J., Hofman, A., Koudstaal, P. J. and Breteler, M. M. (2010). Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology, 75, 1982–1987.
Shulman, K. I., Gold, D. P., Cohen, C. A. and Zucchero, C. A. (1993). Clock drawing and dementia in the community: a longitudinal study. International Journal of Geriatric Psychiatry, 8, 487–496.
Whiting, D. R., Guariguata, L., Weil, C. and Shaw, J. (2011). IDF diabetes atlas: global estimates of teh prevalence of diabetes for 2011 and 2030. Diabetes Research and Clincal Practice, 94, 311–321.
et al. (2013). Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. American Journal of Geriatric Psychiatry (Epub ahead of print). doi:10.1016/j.jagp.2013.01.076.
Wolf-Klein, G. P., Silverstone, F. A., Levy, A. P. and Brod, M. S. (1989). Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatrics Society, 37, 730–734.
Xu, W., Qiu, C., Gatz, M., Pedersen, N. L., Johansson, B. and Fratiglioni, L. (2009). Mid- and late-life diabestes in relation to the risk of dementia: a population-based twin study. Diabetes, 58, 71–77.